Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight

ABSTRACT

Introduction: Impella is a catheter-based micro-axial flow pump placed across the aortic valve, and it is currently the only percutaneous left ventricular assist device approved for high-risk percutaneous coronary intervention and cardiogenic shock.

Areas Covered: Even though several studies have repeatedly demonstrated the excellent hemodynamic profile of Impella in high-risk settings, it remains underutilized. Here we aim to provide an up-to-date summary of the available literature on Impellas use in High risk settings as well as the practical aspects of its usage.

Expert Commentary: Percutaneous coronary interventions in high rsk settings have always been challenging for a physician. Impella 2.5 and CP, have been proven safe, cost effective and feasible in High Risk Percutaneous coronary Interventions with an excellent hemodynamic profile.

KEYWORDS:

• Percutaneous coronary interventions: PCI
• mechanical circulatory support: MCS
• high-risk percutaneous coronary interventions: HRPCI
• cardiogenic shock: CS
• refractory cardiac arrest: RCA
• intra-aortic balloon pump: IABP
• percutaneous ventricular assist device: pVAD
• acute myocardial infarction with cardiogenic shock: AMICS

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Additional information

Funding

This paper was not funded.